top of page
News, Events and Updates
Search
Jul 28, 2016
Anavex Confirms Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients Presented at AAIC
Jul 26, 2016
Anavex Presents 31-Week Efficacy Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients
Jul 26, 2016
Alzheimer's Association International Conference 2016 (AAIC) — July 27, 2016
Jul 23, 2016
Anavex Presents 31-Week Safety Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients
Jul 11, 2016
Anavex to Present at the Alzheimer's Association International Conference (AAIC) 2016
Jul 11, 2016
Alzheimer's Association International Conference 2016 (AAIC) — July 24, 2016
Jun 22, 2016
Anavex to Present at the 2016 Rett Syndrome Symposium
Jun 21, 2016
ANAVEX 2-73 as a Potential Treatment for Rett Syndrom and Other Pediatric or Infantile Disorders
Jun 21, 2016
Anavex Announces U.S. FDA Orphan Drug Designation for ANAVEX 2-73 for Treatment of Infantile Spasms
Jun 14, 2016
2016 Rett Syndrome Symposium
Jun 10, 2016
Sigma-1 Receptor Agonists as Potential Treatment Options for Autism Spectrum Disorders
26
27
28
29
30
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
